IRWD
Ironwood Pharmaceuticals, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$4.26
−0.70%Forward multiples
Based on analyst estimates
- P/E forward
- 3.58x
- P/E 2026E
- 3.47x
- P/E 2027E
- 3.38x
- P/E 2028E
- 2.98x
- P/S forward
- 1.49x
Trailing multiples
Trailing twelve months
- P/E TTM
- 5.35x
- PEG TTM
- 0.11x
- Price / book
- -4.35x
- Price / sales
- 1.81x
- Price / cash flow
- 3.79x
Enterprise value
- Enterprise value
- $1.0B
- EV / sales
- 2.62x
- EV / EBITDA
- 4.23x
- EV / EBIT
- 4.33x
- Market cap
- $703.9M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026